InvestorsObserver
×
News Home

Will Prometheus Biosciences Inc (RXDX) Stay at the Top of the Healthcare Sector?

Friday, June 02, 2023 01:21 PM | InvestorsObserver Analysts

Mentioned in this article

Will Prometheus Biosciences Inc (RXDX) Stay at the Top of the Healthcare Sector?

Prometheus Biosciences Inc (RXDX) is around the top of the Healthcare sector according to InvestorsObserver. RXDX received an overall rating of 94, which means that it scores higher than 94% of stocks. Additionally, Prometheus Biosciences Inc scored a 75 in the Healthcare sector, ranking it higher than 75% of stocks in that sector.

Overall Score - 94
RXDX has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on RXDX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Prometheus Biosciences Inc Stock Today?

Prometheus Biosciences Inc (RXDX) stock is trading at $198.74 as of 1:16 PM on Friday, Jun 2, an increase of $0.09, or 0.05% from the previous closing price of $198.65. Volume today is less active than usual. So far 107,176 shares have traded compared to average volume of 1,171,224 shares. The stock has traded between $198.60 and $198.81 so far today. Click Here to get the full Stock Report for Prometheus Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App